Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma
- Published on 09/02/2024
- Reading time: 4 min.
Richard A Sturm, 1, Darren J Smit, 1, David L Duffy, 1,2, Catriona McLean, 3,4, Richard A Scolyer, 5,6,7,8, Grant A McArthur, 9,10, Anthony T Papenfuss, 11,12, Mitchell S Stark, 1, H Peter Soyer, 1,13, Victoria J Mar 3,14
1 Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Qld, Australia
2 QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia
3 Victorian Melanoma Service, The Alfred Hospital, Melbourne, Vic, Australia
4 Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia
5 Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia
6 Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
7 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, New South Wales, Australia
8 Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
9 Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
10 Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
11 Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
12 Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
13 Dermatology Department, Princess Alexandra Hospital, Brisbane, Qld, Australia
14 School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia
Correspondence: Assoc. Prof. Richard A. Sturm, Email:r.sturm@uq.edu.au
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Dermatology
Receive our newsletter to stay up to date with the latest news in Dermatology